Winslow Evans & Crocker’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

Winslow Evans & Crocker’s Portfolio ZEAL Stock Details ZEAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$8K	Hold	235	–	–	﹤0.01%	1008
2020 Q3	$9K	Hold	235	–	–	﹤0.01%	787
2020 Q2	$8K	Sell	235 -1	-0.4%	-$36	﹤0.01%	793
2020 Q1	$10K	Hold	236	–	–	﹤0.01%	725
2019 Q4	$8K	Hold	236	–	–	﹤0.01%	903
2019 Q3	$6K	Hold	236	–	–	﹤0.01%	952
2019 Q2	$6K	Buy	+236	New	+$4.77K	﹤0.01%	968

Other funds holding ZEAL

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IBT

International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Winslow Evans & Crocker's ZEAL Position: Q4 2020 in Review

Winslow Evans & Crocker held its Zealand Pharma A/S American Depositary Shares (ZEAL) position steady in Q4 2020 at 235 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #1008.

Winslow Evans & Crocker first reported a position in ZEAL in Q2 2019 and has held it in 7 quarters since. The position peaked at $10K in Q1 2020. 14 funds tracked by Wall St. Rank hold ZEAL as of Q4 2020.

Winslow Evans & Crocker held 235 shares of Zealand Pharma A/S American Depositary Shares worth $8K as of Q4 2020.
Winslow Evans & Crocker left its Zealand Pharma A/S American Depositary Shares share count unchanged in Q4 2020.
Zealand Pharma A/S American Depositary Shares made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #1008 holding.
Winslow Evans & Crocker first reported a position in Zealand Pharma A/S American Depositary Shares in Q2 2019 and has held it in 7 quarters since.
Winslow Evans & Crocker's Zealand Pharma A/S American Depositary Shares position peaked at $10K in Q1 2020.
14 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.